GB9816234D0 - Compounds for use in the treatment of inflammation - Google Patents

Compounds for use in the treatment of inflammation

Info

Publication number
GB9816234D0
GB9816234D0 GBGB9816234.0A GB9816234A GB9816234D0 GB 9816234 D0 GB9816234 D0 GB 9816234D0 GB 9816234 A GB9816234 A GB 9816234A GB 9816234 D0 GB9816234 D0 GB 9816234D0
Authority
GB
United Kingdom
Prior art keywords
inflammation
compounds
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9816234.0A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvey William Research Ltd
Original Assignee
Harvey William Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvey William Research Ltd filed Critical Harvey William Research Ltd
Priority to GBGB9816234.0A priority Critical patent/GB9816234D0/en
Publication of GB9816234D0 publication Critical patent/GB9816234D0/en
Priority to AU50560/99A priority patent/AU5056099A/en
Priority to PCT/GB1999/002392 priority patent/WO2000005263A2/fr
Ceased legal-status Critical Current

Links

GBGB9816234.0A 1998-07-24 1998-07-24 Compounds for use in the treatment of inflammation Ceased GB9816234D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9816234.0A GB9816234D0 (en) 1998-07-24 1998-07-24 Compounds for use in the treatment of inflammation
AU50560/99A AU5056099A (en) 1998-07-24 1999-07-22 Compounds for use in the treatment of inflammation
PCT/GB1999/002392 WO2000005263A2 (fr) 1998-07-24 1999-07-22 Composes utilises dans le traitement de l'inflammation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9816234.0A GB9816234D0 (en) 1998-07-24 1998-07-24 Compounds for use in the treatment of inflammation

Publications (1)

Publication Number Publication Date
GB9816234D0 true GB9816234D0 (en) 1998-09-23

Family

ID=10836177

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9816234.0A Ceased GB9816234D0 (en) 1998-07-24 1998-07-24 Compounds for use in the treatment of inflammation

Country Status (3)

Country Link
AU (1) AU5056099A (fr)
GB (1) GB9816234D0 (fr)
WO (1) WO2000005263A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110585215A (zh) * 2019-09-19 2019-12-20 中山大学 氯化血红素及其复合物在医药中的新应用

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002064091A2 (fr) 2001-02-13 2002-08-22 Palatin Technologies, Inc. Metallopeptides de melanocortine pour le traitement de dysfonctions sexuelles
CA2453515A1 (fr) 2001-07-11 2003-01-23 Palatin Technologies, Inc. Peptides lineaires et cycliques specifiques du recepteur de melanocortine
EP1529535A1 (fr) * 2003-11-06 2005-05-11 IPF PharmaCeuticals GmbH Isolation d'un peptide lipolytique humain circulant
DK2842576T3 (en) 2004-01-21 2017-10-16 Novo Nordisk Healthcare Ag Transglutaminase-mediated peptide conjugation
AU2008303922A1 (en) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Use of the peptide His-Ser-Leu-Gly-Lys-Trp-Leu-Gly-His-Pro-Asp-Lys-Phe alone or in combination with the peptide Gly-Ard-Gly-Asp-Asn-Pro-OH as a therapeutic agent
KR20100058554A (ko) * 2007-09-11 2010-06-03 몬도바이오테크 래보래토리즈 아게 치료제로서의 망막 콜린성 뉴런을 위한 신경영양성 인자 （ｎｆｒｃｎ） 및 융모성 고나도트로핀―베타 （１０９―１４５）의 용도
NZ590254A (en) 2008-06-09 2012-07-27 Palatin Technologies Inc Melanocortin receptor-specific cyclic peptides for treatment of sexual dysfunction
CN105037502A (zh) 2009-06-08 2015-11-11 帕拉丁科技公司 黑皮质素受体特异性肽
UY32690A (es) 2009-06-08 2011-01-31 Astrazeneca Ab Péptidos específicos para receptores de melanocortina
EP2440572B1 (fr) 2009-06-08 2017-04-05 Palatin Technologies, Inc. Peptides spécifiques des récepteurs aux mélanocortines à pont lactame
CN102725305B (zh) 2009-11-23 2016-08-24 帕拉丁科技公司 黑皮质素-1受体特异性环肽
EP2504351A4 (fr) 2009-11-23 2013-10-30 Palatin Technologies Inc Peptides linéaires spécifiques du récepteur de la mélanocortine-1

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0146113A3 (fr) * 1983-12-15 1987-08-19 Dieter Aderhold Agent actif et composition thérapeutique pour traitement des défaillances de diencéphalon, des maladies nerveuses et des maladies de la peau
US5674839A (en) * 1987-05-22 1997-10-07 Competitive Technologies, Inc. Cyclic analogs of alpha-MSH fragments
FR2691465B1 (fr) * 1992-05-25 1995-08-11 Pf Medicament Complexes comprenant au moins un peptide derive de l'alpha msh, peptide, microsphere, medicament et composition galenique les comprenant.
US5726156A (en) * 1995-03-06 1998-03-10 Trega Biosciences, Inc. Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110585215A (zh) * 2019-09-19 2019-12-20 中山大学 氯化血红素及其复合物在医药中的新应用
CN110585215B (zh) * 2019-09-19 2023-06-02 中山大学 氯化血红素及其复合物在医药中的新应用

Also Published As

Publication number Publication date
WO2000005263A3 (fr) 2000-05-04
AU5056099A (en) 2000-02-14
WO2000005263A2 (fr) 2000-02-03

Similar Documents

Publication Publication Date Title
IL142908A0 (en) Compounds useful in the treatment of inflammatory diseases
HK1042475A1 (zh) 用於治療炎癥的取代噻唑
HUP0100765A3 (en) Composition for the treatment of halitosis
GB9816234D0 (en) Compounds for use in the treatment of inflammation
HK1022267A1 (en) Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis
HUP0101947A3 (en) Combination for the treatment of tumors
IL155769A0 (en) Method for the treatment of inflammation
AU1940800A (en) Combination therapy for the treatment of sepsis
IL141056A0 (en) Protease inhibitors for use in the treatment of psoriasis
GB9904252D0 (en) Composition for the treatment of pain
GB9810920D0 (en) Therapeutic use
GB9812662D0 (en) Therapeutic use
GB9816897D0 (en) Therapeutic use
GB0020261D0 (en) Therapeutic treatment
GB9811624D0 (en) Therapeutic use
GB9821179D0 (en) Therapeutic use
GB9815497D0 (en) Treatment
GB9818524D0 (en) Inorgasmia treatment
GB9906130D0 (en) Compounds for use in therapy
GB9715202D0 (en) Compounds for the use in the treatment of autism
GB9624022D0 (en) Compounds for use in the treatment of autism
GB9615209D0 (en) Compounds for use in the treatment of autism
GB9812664D0 (en) Therapeutic use
GB9828550D0 (en) Treatment
GB9802622D0 (en) Compounds and their therapeutic use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)